This inventor holds 8 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited. Active years: 2017-2026.
Company Filing History:
4 out of 854 
4 out of 1,226 
Years Active: 2017-2026
Title: Irving H. Fox – A Key Player at Takeda Pharmaceutical Company Limited
Introduction
Irving H. Fox is an influential figure in the pharmaceutical industry, currently associated with Takeda Pharmaceutical Company Limited in the United States. Although he holds no patents to his name, his work at Takeda contributes significantly to innovative developments in healthcare and medication.
Latest Patents
Despite not having any personal patents, Irving's contributions to projects may support further advancements in pharmaceutical inventions. His collaboration with his team continues to foster a culture of innovation within the company.
Career Highlights
At Takeda Pharmaceutical Company Limited, Irving H. Fox engages in vital research and development efforts. His role reflects a commitment to improving patient outcomes through the exploration of new pharmaceutical solutions and treatments.
Collaborations
Irving collaborates closely with talented colleagues, including Willow Diluzio and Nobel T. Truong. Together, they work to streamline processes and enhance the effectiveness of their research initiatives, creating a robust environment for innovations at Takeda.
Conclusion
Irving H. Fox's career illustrates the importance of teamwork and collaboration in the pharmaceutical industry. His contributions to Takeda Pharmaceutical Company Limited, although not defined by personal patents, play a crucial role in fostering advancements that could shape the future of healthcare.